Vyaire Medical Inc‘s Board of Directors has appointed Gaurav Agarwal as chief executive officer, effective immediately, according to a company news announcement.

Agarwal has extensive global leadership experience in medical devices and a proven track record in driving innovation, improving patient outcomes, and creating exceptional value for customers, according to Vyaire. Most recently, as president and chief operating officer of KCI, an Acelity Company, Agarwal transformed the company into an undisputed leader in advanced wound care, by finding ground-breaking healing solutions for current and new customer segments.

Prior to that, Agarwal served as President, Orthopaedic Reconstruction at Smith & Nephew, where he was responsible for defining a cutting-edge global strategy that expedited product development and redefined the company’s portfolio for joint reconstruction. Before that, he held Vice President and General Manager positions at GE Healthcare.

“I’m excited to be joining Vyaire Medical. It has a clear vision and mission, a strong team in place, and a robust pipeline of products to meet the needs of our patients and customers,” said Agarwal. “With a formidable footprint, and the ability to leverage technology to create best-in-class solutions, my focus will be working with the team to push the boundaries on innovation, create additional value for customers and patients, and secure Vyaire’s position as the leader in respiratory care.”

“We are thrilled to welcome Gaurav to Vyaire,” said Steven Dyson, chairman of Vyaire Medical’s board of directors. “He brings a wealth of experience in driving innovation and growing businesses in the medical device industry. In the five years that I’ve known him, I’ve seen first-hand the positive impact of his focus on the customer, his attention to employees, and his ability to create value for shareholders. He is the perfect fit for Vyaire at this time.”

Vyaire’s former CEO Dave Eckley will remain on the company’s board of directors, the company said.